Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer

Ferlay, 2000 Benson, 2000, NCCN practice guidelines for colorectal cancer, Oncology (Huntingt), 14, 203 Meyers, 2003, Locoregional strategies for colorectal hepatic metastases, Clin. Colorectal. Cancer, 3, 34, 10.3816/CCC.2003.n.010 McAneny, 1996, Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer, Ann. Surg. Oncol., 3, 495, 10.1007/BF02305769 Ullenhag, 2003, Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony-stimulating factor induced a tumor-specific cellular immune response, Clin. Cancer Res., 9, 2447 Conry, 2002, Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients, Clin. Cancer Res., 8, 2782 Bremers, 2000, T cell responses in colorectal cancer patients: evidence for class II HLA-restricted recognition of shared tumor-associated antigens, Int. J. Cancer, 88, 956, 10.1002/1097-0215(20001215)88:6<956::AID-IJC19>3.0.CO;2-3 Nair, 2002, Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells, Ann. Surg., 235, 540, 10.1097/00000658-200204000-00013 Nagorsen, 2000, Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer, Cancer Res., 60, 4850 Nagorsen, 2003, Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients, Int. J. Cancer, 105, 221, 10.1002/ijc.11052 Engleman, 2003, Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patients, Clin. Immunol., 106, 10, 10.1016/S1521-6616(02)00016-5 Renkvist, 2001, A listing of human tumor antigens recognized by T cells, Cancer Immunol. Immunother., .50, 3, 10.1007/s002620000169 Dalerba, 2003, Immunology and immunotherapy of colorectal cancer, Crit. Rev. Oncol. Hematol., 46, 33, 10.1016/S1040-8428(02)00159-2 Old, 2001, Cancer/Testis (CT) antigens—a new link between gametogenesis and cancer, Cancer Immun., 1, 1 Chen, 1999, Cancer-testis antigens: targets for cancer immunotherapy, Cancer J. Sci. Am., 5, 16, 10.1111/j.1349-7006.1999.tb00660.x van der Bruggen, 1991, A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science, 254, 1643, 10.1126/science.1840703 De Smet, 1999, DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter, Mol. Cell. Biol., 19, 7327, 10.1128/MCB.19.11.7327 Weiser, 2001, Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1, J.Immunother., 24, 151, 10.1097/00002371-200103000-00010 Eichmüller, 2001, Serological detection of cutaneous T-cell lymphoma-associated antigens, 98, 629 Usener, 2003, cTAGE: a cutaneous T-cell lymphoma associated antigen family with tumor-specific splicing, J. Invest Dermatol., 121, 198, 10.1046/j.1523-1747.2003.12318.x Gaugler, 1996, A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma, Immunogenetics, 44, 323, 10.1007/BF02602776 Eichmüller, 2002, mRNA expression of tumor-associated antigens in melanoma tissues and cell lines, Exp. Dermatol., 11, 292, 10.1034/j.1600-0625.2002.110402.x Usener, 2003, Sero-reactivity against MAGE-A and LAGE-1 proteins in melanoma patients, Br. J. Dermatol., 149, 282, 10.1046/j.1365-2133.2003.05410.x Sahin, 1995, Human neoplasms elicit multiple specific immune responses in the autologous host, PNAS, 92, 11810, 10.1073/pnas.92.25.11810 Coulie, 1993, Genes coding for tumor antigens recognized by human cytolytic T lymphocytes, J. Immunother., 14, 104, 10.1097/00002371-199308000-00004 van den Eynde, 1995, A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma, J. Exp. Med., 182, 689, 10.1084/jem.182.3.689 Mori, 1996, Expression of MAGE genes in human colorectal carcinoma, Ann. Surg., 224, 183, 10.1097/00000658-199608000-00011 Chen, 1997, A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening, PNAS, 94, 1914, 10.1073/pnas.94.5.1914 Lethé, 1998, LAGE-1, a new gene with tumor specificity, Int. J. Cancer, 76, 903, 10.1002/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO;2-1 Türeci, 1998, Expression of SSX genes in human tumors, Int. J. Cancer, 77, 19, 10.1002/(SICI)1097-0215(19980703)77:1<19::AID-IJC4>3.0.CO;2-2 Hoon, 1995, Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen, J. Immunol., 154, 730, 10.4049/jimmunol.154.2.730 Fujii, 2000, Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients, Cancer Gene Ther., 7, 1220, 10.1038/sj.cgt.7700224 Moingeon, 2001, Cancer vaccines, Vaccine, 19, 1305, 10.1016/S0264-410X(00)00372-8 Bergmann-Leitner, 2000, Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack, Cancer Immunol. Immunother., 49, 193, 10.1007/s002620000105 Hasegawa, 1998, Expression spectrum of melanoma antigen-encoding gene family members in colorectal carcinoma, Arch. Pathol. Lab. Med., 122, 551 Inoue, 1995, Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes, Int. J. Cancer, 63, 523, 10.1002/ijc.2910630411 De Backer, 1999, Characterization of the GAGE genes that are expressed in various human cancers and in normal testis, Cancer Res., 59, 3157 Eichmüller, 2003, Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity, Int. J. Cancer, 104, 482, 10.1002/ijc.10967 Scanlan, 2002, Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets, Cancer Res., 62, 4041 Stockert, 1998, A survey of the humoral immune response of cancer patients to a panel of human tumor antigens, J. Exp. Med., 187, 1349, 10.1084/jem.187.8.1349 Serrano, 1999, Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries, Int. J. Cancer, 83, 664, 10.1002/(SICI)1097-0215(19991126)83:5<664::AID-IJC16>3.0.CO;2-V Weynants, 1994, Expression of mage genes by non-small-cell lung carcinomas, Int. J. Cancer, 56, 826, 10.1002/ijc.2910560612 Scarcella, 1999, Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers, Clin. Cancer Res., 5, 335 Türeci, 1996, The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40, Cancer Res., 56, 4766